Skip to main content

Advertisement

SpringerLink
Log in

Membrane transport and the antineoplastic action of nucleoside analogues

  • Published:
Cancer and Metastasis Reviews Aims and scope Submit manuscript

Abstract

This article summarizes recent studies characterizing nucleoside transport in mammalian cells and discusses evidence for a role of membrane transport in the pharmacologic action of nucleoside analogues. Some of these studies have also addressed the controversy concerning the multiplicity in transport routes. It seems clear that erythrocytes and, perhaps, some other mammalian cells possess a single, broadly specific system for transporting nucleosides. However, substantial evidence from valid studies discriminating between transport and intracellular metabolism suggests that at least some mammalian cells, including some tumor cells, possess more than a single system. Evidence now exists for a determining role of membrane transport of nucleoside analogues in their cytotoxicity and, in the case of one pyrimidine nucleoside (AraC), in therapeutic responsiveness in leukemic patients. There are also numerous examples of transport-related resistance to nucleoside analogues. Included in this article are the results of studies from the authors' laboratory pertaining to the therapeutic activity of the purine nucleoside, FAraA, in murine tumor models. These studies provide evidence for a determining role of both membrane transport and intracellular phosphorylation in the selective antitumor action of this agent against murine leukemia. Substantially increased transport inward of FAraA occurs at pharmacologically achievable concentrations of this agent in tumor cells as compared to drug-limiting, normal proliferative epithelium of the small intestine. The basis for this differential appears to be the kinetic duality of FAraA and adenosine transport inward found in tumor cells, but not in proliferative intestinal epithelial cells. Tumor cells have highly saturable (low influx Km) and poorly saturable (high influx Km) systems for adenosine transport, both of which are shared by FAraA. In contrast, proliferative epithelial cells have only a poorly saturable system for these substrates. If a similar kinetic duality of nucleoside transport is found in other tumor cells certain implications arise concerning the significance of the duality to neoplastic transformation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Montgomery JA: Studies on the biologic activity of purine and pyrimidine analogs. Med Res Rev 2: 271–308, 1982

    Google Scholar 

  2. Montgomery JA: The chemistry and biology of nucleosides of purines and ring analogs. In: Rideout JL, Henry DW, Beacham III, LM (eds) Nucleosides, Nucleotides and their Biological Applications. Academic Press, 1983, pp 19–46

  3. Montgomery JA: Has the well gone dry? The first Cain Memorial Award lecture. Cancer Res 42: 3911–3917, 1982

    Google Scholar 

  4. Burchenal JH, Leyland-Jones B, Watanabe K, Klein R, Lopez C, Fox JJ: Experimental and clinical studies on 2-fluoroarabinosyl pyrimidines and purine-like C-nucleosides. In: Rideout JL, Henry DW, Beacham III LM (eds) Nucleosides, Nucleotides and their Biological Applications. Academic Press, New York, 1983, pp 47–65

    Google Scholar 

  5. Marz R, Wohlhueter RM, Plagemann PGW: Purine and pyrimidine transport and phosphoribosylation and their interaction in overall uptake by cultured mammalian cells. A re-evaluation. J Biol Chem 254: 2329–2338, 1979

    Google Scholar 

  6. Plagemann PGW, Wohlhueter RM: Permeation of nucleosides, nucleic acid bases, and nucleotides in animal cells. Curr Top Memb Transp 14: 226–313, 1980

    Google Scholar 

  7. Koren R, Shohami E, Yeroushalmi S: A kinetic analysis of the uptake of cytosine-β-D-arabinoside by rat-B77 cells. Differentiation between transport and phosphorylation. Eur J Biochem 95: 333–339, 1979

    Google Scholar 

  8. Cadman E, Eiferman F, Heimer R, David L: Pyrazofurin enhancement of 5-azacytidine and antitumor activity in L51784 and human leukemia cells. Cancer Res 38: 4610–4617, 1978

    Google Scholar 

  9. Avramis VI, Plunkett W: 2-fluoro-ATP: a toxic metabolite of 9-β-D-arabinosyl-2-fluoroadenine. Biochem Biophys Res Commun 113: 35–43, 1983

    Google Scholar 

  10. Kessel D, Shurin SB: Transport of two nonmetabolized nucleosides, deoxycytidine and cytosine arabinoside in a subline of the L1210 murine leukemia. Biochim Biophys Acta 163: 179–187, 1968

    Google Scholar 

  11. Wiley JS, Jones SP, Sawyer WH, Paterson ARP: Cytosine arabinoside influx and nucleoside transport sites in acute leukemia. J Clin Invest 69: 479–487, 1982

    Google Scholar 

  12. Wiley JS, Jones SP, Sawyer WH, Paterson ARP. Cytosine arabinoside transport by human leukaemic cells. Eur J Cancer Clin Oncol 19: 1067–1074, 1983

    Google Scholar 

  13. White EL, Shaddix SC, Brockman RW, Bennett LL Jr: Comparison of the actions of 9-β-D-arabinofuranosyl-2-fluoroadenine and 9-β-D-arabinofuranosyladenine on target enzymes from mouse tumor cells. Cancer Res 42: 2260–2264, 1982

    Google Scholar 

  14. Chang CH, Cheng YC: Effects of deoxyadenosine triphosphate and 9-β-D-arabinofuranosyladenine-5′-triphosphate on human ribunocleotide reductase from Molt4-F cells and the concept of ‘self-potentiation.’ Cancer Res 40: 3555–3558, 1980

    Google Scholar 

  15. Sato A, Montgomery JA, Cory JG: Synergistic inhibition of leukemia L1210 cell growthin vitro by combinations of 2-fluoroadenine nucleosides and hydroxyurea or 2, 3-dihydro-1H-pyrazole[2, 3-a]imidazole. Cancer Res 44: 3286–3290, 1984

    Google Scholar 

  16. Spriggs D, Robbins G, Mitchell T, Kufe D: Incorporation of 9-β-D-arabinofuranosyl-2-fluoroadenine into HL-60 cellular RNA and DNA. Biochem Pharmacol 35: 247–252, 1986

    Google Scholar 

  17. Fridland A: Selection of 9-β-D-arabinofuranosyl adenineresistant human T-lymphoblasts with altered ribonucleotide reductase activity. Cancer Res 44: 4328–4332, 1984

    Google Scholar 

  18. Cass CE: 9-β-D-arabinofuranosyladenine (AraA). In: Hahn FE (ed.) Antibiotics, Volume 2. Springer-Verlag, Berlin, 1979, pp 85–109

    Google Scholar 

  19. Schewach DS, Daddona PE, Ashcraft E, Mitchell BS: Metabolism and selective cytotoxicity of 9-β-D-arabinofuranosulguanine in human lymphoblasts. Cancer Res 45: 1008–1014, 1985

    Google Scholar 

  20. Kajander EO, Kibota M, Carrera CJ, Montgomery JA, Carson DA: Resistance to multiple adenine nucleoside and methionine analogs in mutant murine lymphoma cells with enlarged S-adenosylmethionine pools. Cancer Res 46: 2866–2870, 1986

    Google Scholar 

  21. Cass CE, Selner M, Phillips JR: Resistance to 9-β-D-arabinofuranosyladenine in cultured leukemia L1210 cells. Cancer Res 43: 4791–4798, 1983

    Google Scholar 

  22. Chou TC, Hutchison DJ, Schmid FA, Phillips FS: Metabolism as selective effects of 1-β-D-arabinofuranosyl cytosine in L1210 and host tissuein vivo. Cancer Res 35: 225–236, 1976

    Google Scholar 

  23. Plunkett W, Cohen SS: Penetration of mouse fibroblasts by 2′-deoxyadenosine 5′-phosphate and incorporation of the nucleotide into DNA. J Cell Physiol 91: 261–270, 1977

    Google Scholar 

  24. Yalowich JC, Goldman ID: Analysis of the inhibitory effects of VP-16–213 (Etoposide) and podophyllotoxin on thymidine transport and metabolism in Ehrilich Ascites tumor cellsin vitro. Cancer Res 44: 984–989, 1984

    Google Scholar 

  25. Cass CE, Paterson ARP: Mediated transport of nucleosides in human erythrocytes. Accelerative exchange diffusion of uridine and thymidine and specificity toward pyrimidine nucleosides as permeants. J Biol Chem 247: 3314–3320, 1972

    Google Scholar 

  26. Wohlhueter RM, Plagemann PGW: The role of transport and phosphorylation in nutrient uptake in cultured animal cells. Int Rev Cytol 64: 171–240, 1980

    Google Scholar 

  27. Sirotnak FM, Chello PL, Brockman RW: Potential for exploitation of transport systems in anticancer drug design. In: DeVita Jr. VT, Busch H (eds) Methods in Cancer Research Volume XVI, Cancer Drug Development Part A. Academic Press, New York, 1979, pp 382–447

    Google Scholar 

  28. Sirotnak FM, DeGraw JI: Selective antitumor action of folate analogs. In: Sirotnak FM, Burchall JJ, Ensminger WD and Montgomery JA (eds) Folate Antagonists as Therapeutic Agents, Volume 2, Pharmacology, Experimental and Clinical Therapeutics. Academic Press, New York, 1984. pp 43–95

    Google Scholar 

  29. Sirotnak FM, DeGraw JI, Moccio DM, Samuels LL, Goutas LJ: New folate analogs of the 10-deaza-aminopterin series. Basis for structural design and biochemical and pharmacological properties. Cancer Chemother Pharmacol 12: 18–25, 1984

    Google Scholar 

  30. Sirotnak FM, DeGraw JI, Schmid FA, Goutas LJ, Moccio DM: New folate analogs of the 10-deaza-aminopterin series. Further evidence for markedly increased antitumor efficacy compared with methotrexate in ascitic and solid murine tumor models. Cancer Chemother Pharmacol 12: 26–30, 1984

    Google Scholar 

  31. Schmid FA, Sirotnak FM, Otter GM, DeGraw JI: New folate analogs of the 10-deaza-aminopterin series: Markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice. Cancer Treat Rep 69: 551–553, 1985

    Google Scholar 

  32. Wohlhueter RM, Marz R, Graff JC, Plagemann PGW: The application of rapid kinetic techniques to the transport of thymidine and 3–0-methyl-glucose into mammalian cells in suspension culture. J Cell Physiol 89: 605–612, 1976

    Google Scholar 

  33. Paterson ARP, Harley ER, Cass CE: Measurement and inhibition of membrane transport of adenosine. In: Paton DM (ed) Methods in Pharmacology, Volume 6. Plenum Press, New York, 1985, pp 165–180.

    Google Scholar 

  34. Perdue JF: Transport across serum-stimulated and virus transformed cell membranes. In: Nicolau C (ed) Virus Transformed Cell Membranes. Academic Press, New York, 1978, pp 186–272

    Google Scholar 

  35. Paterson ARP: Adenosine transport. In: Baer HP, Drummond GI (eds) Physiological and Regulatory Functions of Adenosine and Adenosine Nucleotides. Reven Press, New York, 1979, pp 305–313

    Google Scholar 

  36. Paterson ARP, Kolassa N, Cass CE: Transport of nucleoside drugs in animal cells. Pharmacol Ther 12: 515–536, 1981

    Google Scholar 

  37. Aronow B, Ullman B: Thymidine incorporation in nucleoside transport-deficient lymphoma cells. J Biol Chem 260: 16274–16278, 1985

    Google Scholar 

  38. Sobrero AF, Moir RD, Bertino JR, Handschumacher RE: Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2′-deoxyuridine in the HCT-8 human carcinosarcoma line. Cancer Res 45: 3155–3160, 1985

    Google Scholar 

  39. Aronow B, Ullman B: Genetic analysis of the 6-thiobenzylpurine binding site of the nucleoside transporter in mouse lymphoblasts. Proc Soc Exp Biol Med 179: 463–471, 1985

    Google Scholar 

  40. Aronow B, Allen K, Patrick J, Ullman B: Altered nucleoside transporter in mammalian cells selected for resistance to the physiological effects of nucleoside transport. J Biol Chem 260: 6226–6233, 1986

    Google Scholar 

  41. Plagemann PGW, Wohlhueter RM: Nucleoside transport in mammalian cells and interaction with intracellular metabolism. In: Berne M, Hall TW, Rubio R (eds) Regulatory Function of Adenosine. Martinus Nijhoff Publishers, The Hague/Boston/London, 1983, pp 179–201

    Google Scholar 

  42. Paterson ARP: Transport of nucleosides and nucleoside analogs by animal cells. In: Sartorelli AC, Lazo JS, Bertino JR (eds) Molecular Actions and Targets for Cancer Chemotherapeutic Agents. Academic Press, New York. 1981, pp 213–227

    Google Scholar 

  43. Paterson ARP, Cass CE: Transport of nucleoside drugs in animal cells. In: Goldman ID (ed) Transport of Antineoplastic Agents. Academic Press, 1986, pp 309–329

  44. Chello PL, Sirotnak FM, Dorick DM, Yang CH, Montgomery JA: Initial rate kinetics and evidence for duality of mediated transport of adenosine, related purine nucleosides and nucleoside analogues in L1210 cells. Cancer Res 43: 97–103, 1983

    Google Scholar 

  45. Sirotnak FM, Chello PL, Dorick DM, Montgomery JA: Specificity of systems mediating transport of adenosine, 9-β-D-arabinofuranosyl-2-fluoroadenine, and other purine nucleoside analogues in L1210 cells. Cancer Res 43: 104–109, 1983

    Google Scholar 

  46. Plagemann PGW, Marz R, Wohlhueter RM: Uridine transport in Novikoff rat hepatoma cells and other cell lines and its relationship to uridine phosphorylation and phosphorolysis. J Cell Physiol 97: 49–72, 1978

    Google Scholar 

  47. Cass CE, Belt JA, Paterson ARP: Adenosine transport in cultured cells and erythrocytes. In: Pelleg A, Michaelson EL, Dreyfus LS (eds) Cardiac Electrophysiology and Pharmacology of Adenosine and Adenosine Triphosphate: Basic and Clinical Aspects, Vol 230: Progress in Clinical and Biological Research, 1987, pp 13–40

  48. Eilam Y, Stein WF: Kinetic studies of transport across red cell membranes Methods Membr Biol 2: 283–354, 1974

    Google Scholar 

  49. Heichal O, Ish-Shalom D, Koren R, Stein WD: The kinetic dissection of transport from metabolic trapping during substrate uptake by intact cells. Uridine uptake by quiescent and serum-activated NIL 8 hamster cells and their murine sarcoma virus-transformed counterparts. Biochim Biophys Acta 551: 169–186, 1978

    Google Scholar 

  50. Wohlhueter RM, Plagemann PGW: The role of transport and phosphorylation in nutrient uptake in cultured mammalian cells. Int Rev Cytol 64: 171–240, 1980

    Google Scholar 

  51. Jarvis SM: Trans-stimulation and trans-inhibition of uridine efflux from human erythrocytes by permeant nucleosides. Biochem J 233: 295–297, 1986

    Google Scholar 

  52. Lieb WR, Stein WD: Testing and characterizing the simple carrier. Biochim Biophys Acta 373: 178–196, 1974

    Google Scholar 

  53. Wohlhueter RM, Marz R, Plagemann PGW: Thymidine transport in cultured mammalian cells: Kinetic analysis, temperature dependence and specificity of the transport system. Biochim Biophys Acta 553: 262–283, 1979

    Google Scholar 

  54. Plagemann PGW, Erbe J: Thymidine transport by cultured Novikoff hepatoma cells and uptake by simple diffusion and relationship to incorporation into deoxyribonucleic acid. J Cell Biol 55: 161–178, 1972

    Google Scholar 

  55. Plagemann PGW: Nucleoside transport by Novikoff rat hepatoma cells growing in suspension culture. Specificity and mechanism of transport reactions and relationship to nucleoside incorporation into nucleic acids. Biochim Biophys Acta 233: 688–701, 1971

    Google Scholar 

  56. Plagemann PGW, Richey DP: Transport of nucleosides, nucleic acid bases, choline and glucose by animal cells in culture. Biochim Biophys Acta 344: 263–305, 1974

    Google Scholar 

  57. Marz R, Wohlhueter RM, Plagemann PGW: Metabolic stability of the nucleoside transport system of Novikoff rat hepatoma cells. J Supramol Struct 8: 511–520, 1978

    Google Scholar 

  58. Rozengurt E, Stein WD, Wiggelsworth NM: Uptake of nucleosides in density inhibited cultures of 3T3 cells. Nature (London) 267: 442–444, 1977

    Google Scholar 

  59. Rozengurt E, Mierzejewski K, Wigglesworth N: Uridine transport and phosphorylation in mouse cells in culture: Effect of growth promoting factors, cell cycle transit and ongogenic transformation. J Cell Physiol 97: 241–252, 1978

    Google Scholar 

  60. Schwenk M, Hegazy E, Lopez del Pino V: Uridine uptake by isolated intestinal epithelial cells of guinea pig. Biochim Biophys Acta 805: 370–374, 1984

    Google Scholar 

  61. Le Hir M, Dubach UC: Sodium gradient-energized concentrative transport of adenosine in renal brush border vesicles. Pflügers Arch 401: 58–63, 1984

    Google Scholar 

  62. Le Hir M, Dubach UC: Uphill transport of pyrimidine nucleosides in renal brush border vesicles. Pflügers Arch 404: 238–243, 1985

    Google Scholar 

  63. Spector R, Huntoon S: Specificity and sodium dependence of the active nucleoside transport system in choroid plexus. J Neurochem 42: 1048–1052, 1984

    Google Scholar 

  64. Jakobs ES, Paterson ARP: Sodium-dependent concentrative nucleoside transport in cultured intestinal epithelial cells. Biochem Biophys Res Comm 140: 1028–1035, 1986

    Google Scholar 

  65. Spector R: Thymidine accumulation by choroid plexusin vitro. Arch Biochem Biophys 205: 85–93, 1980

    Google Scholar 

  66. Spector R: Nucleoside transport in choroid plexus mechanism and specificity. Arch Biochem Biophys 216: 693–703, 1982

    Google Scholar 

  67. Ungemach FR, Hegner D: Uptake of thymidine into isolated rat hepatocytes. Evidence for two transport systems. Hoppe-Seyler's Z Physiol Chem 359: 845–856, 1978

    Google Scholar 

  68. Belt JA, Noel LD: Nucleoside transport in Walker 256 rat carcinosarcoma and S49 mouse lymphoma cells. Differences in sensitivity to nitrobenzylthioinosine and thiol reagents. Biochem J 232: 681–688, 1985

    Google Scholar 

  69. Plagemann PGW, Wohlhueter RM: Nucleoside transport in cultured mammalian cells. Multiple forms with different sensitivity to inhibition by nitrobenzylthioinosine or hypoxanthine. Biochim Biophys Acta 773: 39–52, 1984

    Google Scholar 

  70. Plagemann PGW, Wohlhueter RM: Effect of sulfhydryl reagents on nucleoside transport in cultured mammalian cells. Arch Biochem Biophys 233: 489–500, 1984

    Google Scholar 

  71. Bibi O, Schwartz J, Eilam Y, Shohami E, Cabantchik ZI: Nucleoside transport in mammalian cell mambranes. IV. Organomercurials and organomercurial-mercaptonucleosides complexes as probes for nucleoside transport systems in hamster cells. J Membr Biol 39: 159–183, 1978

    Google Scholar 

  72. Heichal O, Bibi O, Katz J, Cabantchik ZI: Nucleoside transport in mammalian cell membranes. III. Kinetic and chemical modification studies of cytosine-arabinoside and uridine transport in hamster cells in culture. J Membr Biol 39: 133–157, 1978

    Google Scholar 

  73. Lum CT, Marz R, Plagemann PGW, Wohlhueter RM: Adenosine transport and metabolism in mouse leukemia cells and in canine thymocytes and peripheral blood leukocytes. J Cell Physiol 101: 173–200, 1979

    Google Scholar 

  74. Paterson ARP, Jakobs ES, Harley ER, Fu N-W, Robins MJ, Cass CE: Inhibition of nucleoside transport. In: Berne RM, Hall TW, Rubio R (eds). Regulatory Function of Adenosine. Martinus Nijhoff Publishers, The Hague /Boston/London, 1983, pp 203–220.

    Google Scholar 

  75. Plagemann PGW, Sheppard JR: Competitive inhibition of the transport nucleosides, hypoxanthine, choline and deoxyglucose by theophylline, papaverine and prostaglandins. Biochim Biophys Res Commun 56: 869–875, 1974

    Google Scholar 

  76. Plagemann PGW, Wohlhueter RM: Inhibition of the transport of adenosine, other nucleosides and hypoxanthine in Novikoff rat hepatoma cells by methylxanthines, papaverine, N6-cyclohexyladenosine and N6-phenylisop-sopyladenosine. Biochem Pharmacol 33: 1783–1788, 1984

    Google Scholar 

  77. Plagemann PGW, Wohlhueter RM, Graff JC, Marz R: Inhibition of carrier-mediated and non-mediated permeation processes by cytochalasin B. In: Tanenbaum SW (ed) Cytochalasins-Biochemical and Cell Biological Aspects. Elsevier/North-Holland Biomedical Press, 1978, pp 445–473

  78. Scholtissek C: Studies on the uptake of nucleic acid precursors into cells in tissue culture. Biochim Biophys Acta 158: 435–447, 1968

    Google Scholar 

  79. Plagemann PGW, Erbe J: The deoxyribonucleoside transport systems of cultured Novikoff rat hepatoma cells. J Cell Physiol 83: 337–343, 1984

    Google Scholar 

  80. Turnheim K, Plank B, Kolassa N: Inhibition of adenosine uptake in human erythrocytes by adenosine-5′-carboxamides, xylosyladenine, dipyridamole, hexobendine, and p-nitrobenzylthioguanosine. Biochem Pharmacol 27: 2191–2197, 1978

    Google Scholar 

  81. Paterson ARP, Lay EY, Dahlig E, Cass CE: A common basis for inhibition of nucleoside transport by dipyridamole and nitrobenzylthioinosine? Mol Pharmacol 18: 40–44, 1980

    Google Scholar 

  82. Jarvis SM, Janmonhamed SN, Young JD: Kinetics of nitrobenzylthioinosine binding to the human erythrocyte nucleoside transporter. Biochem J 216: 661–667, 1983

    Google Scholar 

  83. Plagemann PGW, Kraupp M: Inhibition of nucleoside and nucleobase transport and nitrobenzylthioinosine binding by dilazep and hexobendine. Biochem Pharmacol 35: 2559–2567, 1986

    Google Scholar 

  84. Koren R, Cass CE, Paterson ARP: The kinetics of dissociation of the inhibitor of nucleoside transport nitrobenzylthioinosine from the high-affinity binding sites of cultured hamster cells. Biochem J 216: 299–308, 1983

    Google Scholar 

  85. Dawicki DD, Agrawal KC, Parks Jr. RE: Role of adenosine uptake and metabolism by blood cells in the antiplatelet actions of dipyridamole, dilazep and nitrogenzylthioinosine. Biochem Pharmacol 34: 3965–3972, 1985

    Google Scholar 

  86. Paterson ARP, Oliver JM: Nucleoside transport II. Inhibition by p-nitrobenzylthioguanosine and related compounds. Can J Biochem 49: 271–274, 1971

    Google Scholar 

  87. Pickard MA, Paterson ARP: Use of 4-nitrobenzylthioinosine in the measurement of rates of nucleoside transport in human erythrocytes. Can J Biochem 50: 839–840, 1972

    Google Scholar 

  88. Pickard MA, Brown RR, Paul B, Paterson ARP: Binding of the nucleoside transport inhibitor 4-nitrobenzylthioinosine to erythrocyte membranes. Can J Biochem 51: 666–672, 1973

    Google Scholar 

  89. Cass CE, Gaudette LA, Paterson ARP: Mediated transport of nucleosides in human erythrocytes. Specific binding of the inhibitor nitrobenzylthioinosine to nucleoside transport sites in the erythrocyte membranes. Biochim Biophys Acta 345: 1–10, 1974

    Google Scholar 

  90. Jarvis SM, Hammond JR, Paterson ARP, Clanachan AS: Species differences in nucleoside transport: a study of uridine transport and nitrobenzylthioinosine binding by mammalian erythrocytes. Biochem J 208: 83–88, 1982

    Google Scholar 

  91. Lauzon GJ, Paterson ARP: Binding of the nucleoside transport inhibitor introbenzylthioinosine to cultured HeLa cells. Mol Pharmacol 13: 883–891, 1977

    Google Scholar 

  92. Cass CE, Kolassa N, Uehara Y, Dahlig-Harley E, Harley ER, Paterson ARP: Absence of binding sites for the transport inhibitor nitrobenzylthioinosine on nucleoside transport-deficient mouse lymphoma cells. Biochim Biophys Acta 649: 769–777, 1981

    Google Scholar 

  93. Dahlig-Harley E, Eilam Y, Paterson ARP, Cass CE: Binding of nitrobenzylthioinosine to high affinity sites on the nucleoside transport mechanism of HeLa cells. Biochem J 200: 295–305, 1981

    Google Scholar 

  94. Eilam Y, Cabantchik ZI: Nucleoside transport in mammalian cell membranes: A specific inhibitory mechanism of high affinity probes. J Cell Physiol 92: 185–202, 1977

    Google Scholar 

  95. Wohlhueter RM, Marz R, Plagemann PGW: Properties of the thymidine transport system of Chinese hamster ovary cells as probed by nitrobenzylthioinosine. J Membr Biol 42: 247–264, 1979

    Google Scholar 

  96. Cohen AC, Leung C, Thompson E. Characterization of mouse lymphoma cells with altered nucleoside transport. J Cell Physiol 123: 431–434, 1985

    Google Scholar 

  97. Young JD, Jarvis SM, Robins MF, Paterson ARP: Photoaffinity labelling of the human erythrocyte nucleoside transporter by N6-(p-azidobenzyl) adenosine and nitrobenzylthioinosine. J Biol Chem 258: 2202–2208, 1983

    Google Scholar 

  98. Shi MM, Wu J-S, Lee C-M, Young JD: Nucleoside transport. Photoaffinity labelling of high-affinity nitrobenzylthioinosine binding sites in rat and guinea pig lung. Biochem Biophys Res Comm 118: 594–600, 1984

    Google Scholar 

  99. Kwan KF, Jarvis SM: Photoaffinity labelling of the adenosine transporter in cardiac membranes with nitrobenzylthioinosine. Am J Physiol 246: H710-H715, 1984

    Google Scholar 

  100. Young JC, Jarvis SM, Belt JA, Gati WP, Paterson ARP: Identification of the nucleoside transporter in cultured mouse lymphoma cells. J Biol Chem 259: 8363–8365, 1984

    Google Scholar 

  101. Jarvis SM, Ng AS: Identification of the adenosine uptake sites in guinea pig brain. J Neurochem 44: 183–188, 1985

    Google Scholar 

  102. Tse C-M, Belt JA, Jarvis SM, Paterson ARP, Wu J-S, Young JD: Reconstitution studies of the human erythrocyte nucleoside transporter. J Biol Chem 260: 3506–3511, 1985

    Google Scholar 

  103. Janmohamed S, Young JD, Jarvis SM: Proteolytic cleavage of3[H]nitrobenzylthioinosine-labelled nucleoside transporter in human erythrocytes. Biochem J 230: 777–784, 1985

    Google Scholar 

  104. Kwong FYP, Baldwin SA, Scudder PR, Jarvis SM, Choy MYM, Young JD: Erythrocyte nucleoside and sugar transport. Endo-β-galactosidase and endoglycosidase-F digestion of partially purified human and pig transporter proteins. Biochem J 240: 349–356, 1986

    Google Scholar 

  105. Paterson ARP, Kolassa N, Lynch TP, Jakobs ES, Cass CE: Transport of nucleosides in animal cells. In: Tattersall MHN, Fox RM (eds) Nucleosides and Cancer Treatment. Academic Press, New York, 1981, pp 3–17

    Google Scholar 

  106. Christensen HN: Biological Transport. WA Benjamin, Reading, MA, 1975

    Google Scholar 

  107. Belt JA: Heterogeneity of nucleoside transport in mammalian cells. Two types of transport activity in L1210 and other cultured neoplastic cells. Mol Pharmacol 24: 479–484, 1983

    Google Scholar 

  108. Belt JA: Nitrobenzylthioinosine-insensitive uridine transport in human lymphoblastoid and murine leukemia cells. Biochem Biophys Res Commun 110: 417–423, 1983

    Google Scholar 

  109. Aronow B, Toll D, Patrick J, McCartan K, Ullman B: Dipyridamole-insensitive nucleoside transport in mutant murine T lymphoma cells. J Biol Chem 261: 14467–14473, 1986

    Google Scholar 

  110. Plagemann PGW, Wohlhueter RM: Nitrobenzylthioinosine-sensitive and resistant nucleoside transport in normal and transformed rat cells. Biochim Biophys Acta 816: 387–395, 1985

    Google Scholar 

  111. Paterson ARP, Jakobs ES, Harley ER, Cass CE, Robins MJ: Inhibitors of nucleoside transport as probes and drugs. In: Cheng Y-C, Goz B, Minkoff M (eds) Development of Target-Oriented Anticancer Drugs. Raven Press, New York, 1983, pp 41–56

    Google Scholar 

  112. Plagemann PGW, Wohlhueter RM: Hypoxanthine transport in mammalian cells: cell type-specific differences in sensitivity to inhibition by dipyridamole and uridine. J Membr Biol 81: 255–262, 1984

    Google Scholar 

  113. Barrueco JR, Jacobsen DM, Chang C-H, Brockman RW, Sirotnak FM: Proposed mechanism of therapeutic selectivity for 9-β-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative in intestinal epithelium compared to tumor cells. Cancer Res 47: 700–706, 1987

    Google Scholar 

  114. Ahluwalia GS, Cohen MB, Kang G-J, Arnold ST, McMahon JB, Dalal M, Wilson YA, Cooney DA, Balzarini J, Johns DG: Arabinosyl-5-azacytosine: Mechanisms of native and acquired resistance. Cancer Res 46: 4479–4485, 1986

    Google Scholar 

  115. White JC, Hines LH, Rathmell JP: Inhibition of 1-β-D-arabinofuranocytosine transport and net accumulation by teniposide and etoposide in Ehrlich ascites cells and human leukemic blasts. Cancer Res 45: 3070–3075, 1985

    Google Scholar 

  116. Grem JL, Fischer PH: Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole. Cancer Res 45: 2967–2972, 1985

    Google Scholar 

  117. Plagemann PGW, Marz R, Wohlhueter RM: Transport and metabolism of deoxycytidine and 1-β-D-arabinofuranosylcytosine into cultured Novikoff rat hepatoma cells. J Biol Chem 252: 4191–4201, 1978

    Google Scholar 

  118. Cass CE, Paterson ARP: Mediated transport of nucleosides by human erythrocytes. Specificity toward purine nucleosides as permeants. Biochim Biophys Acta 291: 734–746, 1973

    Google Scholar 

  119. Plagemann PGW, Marz R, Wohlhueter RM: Transport and metabolism of deoxycytidine and 1-β-D-arabinofuranosyl cytosine into cultured Novikoff rat hepatoma cells, relationship to phosphorylation and regulation of triphosphate synthesis. Cancer Res 3: 978–989, 1978

    Google Scholar 

  120. Plagemann PGW, Behrens M, Abraham D: Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyazofurin. Cancer Res 38: 2458–2466, 1978

    Google Scholar 

  121. Belt JA, Welch AD: Transport of uridine and 6-azauridine in human lymphoblastoid cells. Specificity for the uncharged 6-azauridine molecule. Mol Pharmacol 23: 153–158, 1983

    Google Scholar 

  122. Dahlig-Harley E, Paterson ARP, Robins MJ, Cass CE: Transport of uridine and 3-deazauridine in cultured human lymphoblastoid cells. Cancer Res 44: 161–165, 1984

    Google Scholar 

  123. Bowen D, Diasio RB, Goldman ID: Distinguishing between membrane transport and intracellular metabolism of fluorodeoxyuridine in Ehrlich ascites tumor cells by application of kinetic and high performance liquid chromatographic techniques. J Biol Chem 254: 5333–5339, 1979

    Google Scholar 

  124. Kessel D: Transport of a non-phosphorylated nucleoside, 5′-deoxyadenosine by murine leukemia L1210 cells. J Biol Chem 253: 400–403, 1978

    Google Scholar 

  125. Rogler-Brown T, Agarwal RP, Parks Jr. RE: Tight-binding inhibitors-VI. Interactions of deoxycoformycin and adenosine deaminase in intact human erythrocytes and Sarcoma 180 cells. Biochem Pharmacol 27: 2289–2296, 1978

    Google Scholar 

  126. Rogler-Brown T, Parks Jr. RE: Tight binding inhibitors-VIII. Studies of the interactions of 2′-deoxycoformycin and transport inhibitors with the erythrocytic nucleoside transport system. Biochem Pharmacol 29: 2491–2497, 1980

    Google Scholar 

  127. Chen S-F, Stoekler JD, Parks Jr. BE: Transport of deoxycoformycin in human erythrocytes: measurement by adenosine deaminase titration and radioisotope assay. Biochem Pharmacol 33: 4069–4079, 1984

    Google Scholar 

  128. Harley ER, Paterson ARP, Cass CE: Initial rate of kinetics of the transport of adenosine and 4-amino-7-(β-D-ribofuranosyl)pyrole [2, 3-d] pyrimidine (tubercidin) in cultured cells. Cancer Res 42: 1289–1295, 1982

    Google Scholar 

  129. Paterson ARP, Yang S, Lau EY, Cass CE: Low specificity of the nucleoside transport mechanism of RPMI 6410 cells. Mol Pharmacol 16: 900–908, 1979

    Google Scholar 

  130. Cass CE, Selner M, Tan TH, Muhs WH, Robins MJ: Comparison of the effects on cultured L1210 leukemia cells of the ribosyl, 2′-deoxyribosyl and xylosyl homologs of tubercidin and adenosine alone or in combination with 2′-deoxycoformycin. Cancer Treat Rep 66: 317–326, 1982

    Google Scholar 

  131. Montgomery JA, Hewson K: Synthesis of potential antitumor agents. X. 2-fluoroadenosine. J Am Chem Soc 79: 4559–4560, 1957

    Google Scholar 

  132. Montgomery JA, Johnston TP, Gallagher A, Stringfellow CR, Schabel FM: A comparative study of the anticancer activity of some S-substituted derivatives of 6-mercaptopurine and their ribonucleosides. J Med Pharm Chem 3: 265–288, 1961

    Google Scholar 

  133. Montgomery JA, Hewson K: Nucleosides of 2-fluoroadenosine. J Med Chem 12: 498–504, 1969

    Google Scholar 

  134. Montgomery JA, Clayton SD, Shortnancy AT: An improved procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine. J Heterocycl Chem 16: 157–160, 1979

    Google Scholar 

  135. Brockman RW, Schabel FM Jr., Montgomery JA: Biologic activity of 9-β-D-arabinofuranosyladenine. Biochem Pharmacol 26: 2193–2196, 1977

    Google Scholar 

  136. Brockman RW, Cheng Y-C, Schabel FM Jr., Montgomery JA: Metabolism and chemotherapeutic activity of 9-β-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase. Cancer Res 40: 3610–3615, 1980

    Google Scholar 

  137. Avramis VI, Plunkett W: Metabolism and therapeutic efficacy of 9-β-D-arabinofuranosyl-2-fluoroadenine against murine leukemia P 388. Cancer Res 42: 2587–2591, 1982

    Google Scholar 

  138. Plunkett W, Chubb S, Alexander L, Montgomery JA: Comparison of the toxicity and metabolism of 9-β-D-arabinofuranosyl-2-fluoroadenine and 9-β-D-arabinofuranosyladenine in human lymphoblastoid cells. Cancer Res 40: 2349–2355, 1980

    Google Scholar 

  139. Tseng WC, Derse D, Cheng YC, Brockman RW, Bennett Jr. LL:In vitro biological activity of 9-β-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate o on DNA polymerases and ribonucleotide reductase from HeLa cells. Mol Pharmacol 21: 474–477, 1982

    Google Scholar 

  140. Weiser MM: Intestinal epithelial cell surface membrane glycoprotein synthesis. I. An indicator of cellular differentiation. J Biol Chem 248: 2536–2541, 1973

    Google Scholar 

  141. Chang C-H, Brockman RW, Bennett Jr. LL: Adenosine kinase from L1210 cells. Purification and some properties of the enzyme. J Biol Chem 255: 2366–2371, 1980

    Google Scholar 

  142. Chang C-H, Brockman RW, Bennett Jr. LL: Purification and some properties of a deoxyribonucleoside kinase from L1210 cells. Cancer Res, 42: 3033–3039, 1982

    Google Scholar 

  143. Breslow RW, Goldsby RA: Isolation and characterization of thymidine transport mutants of Chinese hamster cells. Exp Cell Res 55: 339–346, 1969

    Google Scholar 

  144. Freed JJ, Mezger-Freed L: Origin of thymidine kinase deficient (TK-) haploid frog cells via an intermediate thymidine transport deficient (TT-) phenotype. J Cell Physiol 82: 199–212, 1973

    Google Scholar 

  145. Freed JJ, Hames IM: Loss of a thermolabile thymidine kinase activity in bromodeoxyuridine resistant (transport deficient kinase positive) haploid cultured frog cells. Exp Cell Res 99: 126–134, 1976

    Google Scholar 

  146. Lynch TP, Cass CE, Paterson ARP: Defective transport of thymidine by cultured cells resistant to 5-bromodeoxyuridine. J Supramol Struct 6: 363–374, 1977

    Google Scholar 

  147. Cohen A, Ullman B, Martin DW: Characterization of a mutant mouse lymphoma cell with deficient transport of purine and pyrimidine nucleosides. J Biol Chem 254: 112–116, 1979

    Google Scholar 

  148. Sobrero AF, Handschumacher RE, Bertino JR: Highly selective drug combinations for human colon cancer cells resistantin vitro to 5-fluoro-2′-deoxyuridine. Cancer Res 45: 3161–3163, 1985

    Google Scholar 

  149. Lynch TP, Jakobs ES, Paran JH, Paterson ARP: Treatment of mouse neoplasms with higher doses of tubercidin. Cancer Res 41: 3200–3204, 1981

    Google Scholar 

  150. Lynch TP, Paran JH, Paterson ARP: Therapy of mouse leukemia L1210 with combinations of nebularine and nitrobenzylthioinosine-5′-monophasphate. Cancer Res 41: 560–565, 1981

    Google Scholar 

  151. King ME, Naporn A, Young B, Howell SB: Modulation of cytarabine uptake and toxicity by dipyridamole. Cancer Treat Rept 68: 361–366, 1984

    Google Scholar 

  152. Cabral S, Leis S, Bover L, Nembrot M, Mordoh J: Dipyridamole inhibits reversion by thymidine of methotrexate effect and increases drug uptake in Sarcoma 180 cells. Proc Natl Acad Sci 81: 3200–3203, 1984

    Google Scholar 

  153. Nelson JA, Drake S: Potentiation of Methotrexate toxicity by dipyridamole. Cancer Res 44: 2493–2496, 1984

    Google Scholar 

  154. Paterson ARP, Paran JH, Yang S, Lynch TP: Protection of mice against lethal dosages of nebularine by nitrobenzylthioinosine, an inhibitor of nucleoside transport. Cancer Res 39: 3607–3611, 1979

    Google Scholar 

  155. Kolassa N, Jakobs ES, Buzell GR, Paterson ARP: Manipulation of toxicity and tissue distribution of tubercidin in mice by nitrobenzylthioinosine 5′-phosphate. Biochem Pharmacol 31: 1863–1874, 1982

    Google Scholar 

  156. Kolassa N, Paterson ARP, Chou T-C: Modification by nitrobenzylthioinosine-5′-monophosphate of pseudoisocytidine pharmacokinetics in mice and rats through inhibition of membrane transport. Cancer Treat Repts 67: 51–58, 1983

    Google Scholar 

  157. Zhen Y-S, Lui MS, Weber G: Effects of acivicin and dipyridamole on hepatoma 3924A cells. Cancer Res 43: 1616–1619, 1983

    Google Scholar 

  158. Fischer PH, Pamukcu R, Bittner G, Willson JKV: Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole. Cancer Res 44: 3355–3359, 1984

    Google Scholar 

  159. Kennedy DG, Van de Berg HW, Clarke R, Murphy RF: Enhancement of methotrexate cytotoxicity towards the MDA.MB.436 human breast cancer cell line by dipyridamole. Biochem Pharmacol 35: 3053–3056, 1986

    Google Scholar 

  160. Chan TCK, Howell SB: Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in human ovarian carcinoma cell line. Cancer Res 45: 3598–3604, 1985

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory for Molecular Therapeutics, Memorial Sloan-Kettering Cancer Center, 10021, New York, N.Y., USA

    F. M. Sirotnak & J. R. Barrueco

Authors
  1. F. M. Sirotnak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. R. Barrueco
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sirotnak, F.M., Barrueco, J.R. Membrane transport and the antineoplastic action of nucleoside analogues. Cancer Metast Rev 6, 459–480 (1987). https://doi.org/10.1007/BF00047462

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00047462

Key words

Search

Navigation